次世代シーケンシングライブラリー調製の市場規模、シェア、動向分析レポート：シーケンシングタイプ別、製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

次世代シーケンシングライブラリー調製市場の成長と動向：

次世代シーケンシングライブラリー調製の世界市場規模は、2030年には36億4,000万米ドルと推定され、遺伝性疾患の有病率の増加、シーケンシングコストの低下、疾患診断におけるNGSの使用率の上昇により、2024年から2030年にかけてCAGR 13.0%で成長すると予測されています。

さらに、多くの市場参入企業が、NGSベースの解析の特定の要件に適合するように、NGSライブラリー調製のための幅広いソリューションを提供しています。

シーケンシング技術の進歩が疾患パネルの需要を押し上げます。NGSライブラリーは、疾患の原因となる特定の遺伝子のヌクレオチド増幅とシーケンシングによって調製されます。疾患診断パネルは、疾患状態の特定の遺伝的特徴を分析するために精密に設計されています。例えば、2022年2月、OncoDNAは、転座、体細胞変異、ゲノムシグネチャー、がん治療を支援する予測バイオマーカーを解析するためのOncoDEEPキットを発表しました。このキットは腫瘍の変異負荷、マイクロサテライト不安定性、ヘテロ接合性の消失も効果的に測定します。

COVID-19の大流行は、メタゲノミクスと診断のためのシーケンシング技術の採用に大きな影響を与えました。さらに、複数の主要企業がCOVID-19やその他のウイルス感染症に対するNGSベースの診断検査を開始しました。例えば、2021年4月、QIAGEN N.V.は、COVID-19ゲノムの濃縮とSARS-CoV-2ゲノムの配列を得るためのライブラリー調製ソリューションに使用する、初のQIAseq SARS-CoV-2診断キットをリリースしました。

さらに、疾病の発生率の増加や新規創薬への需要が、市場の成長を後押ししています。例えば、2022年9月、IDT社は、NGSライブラリーの構築によるウイルスDNAを用いたジェノタイピングにより、サル痘ウイルス感染を正確に検出するためのNGSライブラリー調製ソリューション、xGen monkeypox virus amplicon panelを発表しました。

全ゲノムシークエンシングは、様々な疾患の原因となる変異を特徴とする表現力豊かなバイオマーカーを検出することにより、希少な遺伝性疾患を検出するために本質的に使用されます。さらに、全ゲノムシーケンシング（WGS）は、希少疾患における新規遺伝子変異の検出に使用されます。例えば、2022年1月、スタンフォード大学の研究者は、希少疾患診断のための記録的な診断率で最小のターンアラウンドタイムで全ヒトゲノムをシーケンシングすることにより、シーケンシング技術としては史上初のギネス記録を確保しました。

次世代シーケンシングライブラリー調製市場レポートハイライト

• シーケンシングタイプ別では、疾患の原因となるゲノム配列の疾患特異的解析の需要から、ターゲットゲノムシーケンシングがNGSライブラリー調製市場で大きなシェアを占めると予測されます。
• 製品別では、NGSライブラリー調製キットが研究者や臨床医に提供できる実用的な利点から、試薬・消耗品セグメントが大きな市場シェアを占めると予想されます。すぐに使えるNGSライブラリー調製キットは、専門知識を必要とせず、実験室のインフラも最小限で済みます。
• 用途別では、新薬・バイオマーカー探索分野が市場を席巻しているが、これは広範な疾患に対する新薬・バイオマーカー探索の需要が高まっているためです。
• 最終用途別では、がん、遺伝性疾患、その他の疾患の発生率が世界的に上昇していることから、病院・クリニック分野が予測期間中に急成長する見込みです。遺伝子レベルの理解の高まりもこのセグメントの成長にプラスに働く。
• 北米は、2022年に世界のNGSライブラリ調製市場を独占したが、これは疾患の有病率の上昇、早期診断の需要の増加、ゲノムシーケンシングの必要性、主要市場プレイヤーの存在によるものです。
• NGSライブラリー調製市場の主要プレーヤーには、Agilent Technologies, Inc.、Integrated DNA Technologies、F. Hoffmann-La Roche AG, Inc.、Illumina, Inc.、Beckman Coulter Inc.（Danaher Corporation）、Becton、Merck KGaA、Dickinson and Company、New England Biolabs, Inc.、PerkinElmer Inc.、QIAGEN N.V.、Pacific Biosciences of Californiaが含まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場の系譜
• 次世代シーケンシングライブラリー調製市場-市場力学
• 市場分析ツール

第4章 次世代シーケンシングライブラリー調製市場：シーケンシングタイプ別ビジネス分析

• シーケンシングタイプ別セグメントダッシュボード
• 世界の次世代シーケンシングライブラリー調製市場のシーケンシングタイプ別変動分析、2023年および2030年
• 次世代シーケンシングライブラリー調製の世界市場規模と動向分析、シーケンシングタイプ別、2018～2030年
• 標的ゲノムシーケンシング
• 全ゲノム配列解析
• 全エクソーム配列解析
• その他のシーケンシングタイプ

第5章 次世代シーケンシングライブラリー調製市場：製品別ビジネス分析

• 製品別セグメントダッシュボード
• 世界の次世代シーケンシングライブラリー調製市場の製品別変動分析、2023年および2030年
• 次世代シーケンシングライブラリー調製の世界市場規模と動向分析、製品別、2018～2030年
• 試薬・消耗品
• 機器

第6章 次世代シーケンシングライブラリー調製市場：用途別ビジネス分析

• 用途別セグメントダッシュボード
• 世界の次世代シーケンシングライブラリー調製市場の用途別変動分析、2023年および2030年
• 次世代シーケンシングライブラリー調製の世界市場規模と動向分析、用途別、2018～2030年
• 医薬品およびバイオマーカーの発見
• 病気の診断
• その他

第7章 次世代シーケンシングライブラリー調製市場：最終用途別ビジネス分析

• 最終用途別セグメントダッシュボード
• 世界の次世代シーケンシングライブラリー調製市場の最終用途別変動分析、2023年および2030年
• 世界の次世代シーケンシングライブラリー調製市場規模と動向分析（最終用途別、2018年～2030年）
• 病院と診療所
• 学術研究機関
• 製薬・バイオテクノロジー企業
• その他

第8章 次世代シーケンシングライブラリー調製市場：シーケンシングタイプ、製品、用途、最終用途別の地域別推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG, Inc.
  • Danaher Corporation
  • BD
  • Merck KGaA
  • Oxford Nanopore Technologies
  • New England Biolabs Inc.
  • Revvity, Inc.
  • QIAGEN NV
  • Pacific Biosciences of California, Inc.
  • Thermo Fisher Scientific Inc.
  • Tecan Group Ltd

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 4 Global next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 5 Global next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 6 Global next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 7 Global next-generation sequencing library preparation market, by region, 2018 - 2030 (USD Million)
• Table 8 North America next-generation sequencing library preparation market, by country, 2018 - 2030 (USD Million)
• Table 9 North America next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 10 North America next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 11 North America next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 12 North America next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 13 U.S. Next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 14 U.S. Next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 15 U.S. Next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 16 U.S. Next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 17 Canada next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 18 Canada next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 19 Canada next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 20 Canada next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 21 Mexico next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 22 Mexico next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 23 Mexico next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 24 Mexico next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 25 Europe next-generation sequencing library preparation market, by country, 2018 - 2030 (USD Million)
• Table 26 Europe next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 27 Europe next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 28 Europe next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 29 Europe next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 30 UK next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 31 UK next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 32 UK next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 33 UK next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 34 Germany next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 35 Germany next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 36 Germany next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 37 Germany next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 38 France next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 39 France next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 40 France next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 41 France next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 42 Italy next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 43 Italy next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 44 Italy next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 45 Italy next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 46 Spain next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 47 Spain next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 48 Spain next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 49 Spain next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 50 Denmark next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 51 Denmark next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 52 Denmark next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 53 Denmark next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 54 Sweden next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 55 Sweden next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 56 Sweden next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 57 Sweden next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 58 Norway next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 59 Norway next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 60 Norway next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 61 Norway next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific next-generation sequencing library preparation market, by country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 67 Japan next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 68 Japan next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 69 Japan next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 70 Japan next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 71 China next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 72 China next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 73 China next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 74 China next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 75 India next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 76 India next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 77 India next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 78 India next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 79 Australia next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 80 Australia next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 81 Australia next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 82 Australia next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 83 Thailand next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 84 Thailand next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 85 Thailand next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 86 Thailand next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 87 South Korea next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 88 South Korea next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 89 South Korea next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 90 South korea next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 91 Latin America next-generation sequencing library preparation market, by country, 2018 - 2030 (USD Million)
• Table 92 Latin America next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 93 Latin America next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 94 Latin America next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 95 Latin America next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 96 Brazil next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 97 Brazil next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 98 Brazil next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 99 Brazil next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 100 Argentina next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 101 Argentina next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 102 Argentina next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 103 Argentina next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 104 MEA next-generation sequencing library preparation market, by country, 2018 - 2030 (USD Million)
• Table 105 MEA next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 106 MEA next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 107 MEA next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 108 MEA next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 109 South Africa next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 110 South Africa next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 111 South Africa next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 112 South Africa next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 117 UAE next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 118 UAE next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 119 UAE next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 120 UAE next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 121 Kuwait next-generation sequencing library preparation market, by product, 2018 - 2030 (USD Million)
• Table 122 Kuwait next-generation sequencing library preparation market, by sequencing type, 2018 - 2030 (USD Million)
• Table 123 Kuwait next-generation sequencing library preparation market, by application, 2018 - 2030 (USD Million)
• Table 124 Kuwait next-generation sequencing library preparation market, by end use, 2018 - 2030 (USD Million)
• Table 125 Participant's overview
• Table 126 Financial performance
• Table 127 Key companies undergoing expansions
• Table 128 Key companies undergoing acquisitions
• Table 129 Key companies undergoing collaborations
• Table 130 Key companies launching new products/services
• Table 131 Key companies undergoing partnerships
• Table 132 Key companies undertaking other strategies

List of Figures

• Fig. 1 Next-generation sequencing library preparation market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Next-generation sequencing library preparation market: Sequencing type outlook and key takeaways
• Fig. 20 Next-generation sequencing library preparation market: Sequencing type market share analysis, 2023 & 2030
• Fig. 21 Global targeted genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 22 Global whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 23 Global whole exome sequencing market, 2018 - 2030 (USD Million)
• Fig. 24 Global other sequencing types market, 2018 - 2030 (USD Million)
• Fig. 25 Next-generation sequencing library preparation market: Product outlook and key takeaways
• Fig. 26 Next-generation sequencing library preparation market: Product market share analysis, 2023 & 2030
• Fig. 27 Global instruments market, 2018 - 2030 (USD Million)
• Fig. 28 Global reagents & consumables market, 2018 - 2030 (USD Million)
• Fig. 29 Global DNA library preparation kits market, 2018 - 2030 (USD Million)
• Fig. 30 Global library preparation kits market, 2018 - 2030 (USD Million)
• Fig. 31 Global RNA library preparation kits market, 2018 - 2030 (USD Million)
• Fig. 32 Global other reagents & consumables market, 2018 - 2030 (USD Million)
• Fig. 33 Next-generation sequencing library preparation market: Application outlook and key takeaways
• Fig. 34 Next-generation sequencing library preparation market: Application market share analysis, 2023 & 2030
• Fig. 35 Global drug & biomarker discovery market, 2018 - 2030 (USD Million)
• Fig. 36 Global disease diagnostics market, 2018 - 2030 (USD Million)
• Fig. 37 Global cancer diagnostics market, 2018 - 2030 (USD Million)
• Fig. 38 Global reproductive health diagnostics market, 2018 - 2030 (USD Million)
• Fig. 39 Global infectious disease diagnostics market, 2018 - 2030 (USD Million)
• Fig. 40 Global other disease diagnostics market, 2018 - 2030 (USD Million)
• Fig. 41 Global other applications market, 2018 - 2030 (USD Million)
• Fig. 42 Next-generation sequencing library preparation market: End-use outlook and key takeaways
• Fig. 43 Next-generation sequencing library preparation market: End-use market share analysis, 2023 & 2030
• Fig. 44 Global academic & research institutes market, 2018 - 2030 (USD Million)
• Fig. 45 Global hospitals & clinics market, 2018 - 2030 (USD Million)
• Fig. 46 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 47 Global others market, 2018 - 2030 (USD Million)
• Fig. 48 Regional marketplace outlook, 2023 & 2030 (USD Million)
• Fig. 49 Regional marketplace: Key takeaways
• Fig. 50 North America next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 U.S. key country dynamics
• Fig. 52 U.S. next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Canada key country dynamics
• Fig. 54 Canada next-generation sequencing library preparation market, 2018 - 2030 (USD Million)
• Fig. 55 Mexico key country dynamics
• Fig. 56 Mexico next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Europe next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 UK key country dynamics
• Fig. 59 UK next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Germany key country dynamics
• Fig. 61 Germany next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 France key country dynamics
• Fig. 63 France next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Italy key country dynamics
• Fig. 65 Italy next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Spain key country dynamics
• Fig. 67 Spain next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Denmark key country dynamics
• Fig. 69 Denmark next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Sweden key country dynamics
• Fig. 71 Sweden next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Norway key country dynamics
• Fig. 73 Norway next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Asia-pacific next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Japan key country dynamics
• Fig. 76 Japan next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 China key country dynamics
• Fig. 78 China next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 India key country dynamics
• Fig. 80 India next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Australia key country dynamics
• Fig. 82 Australia next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Thailand key country dynamics
• Fig. 84 Thailand next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 South Korea key country dynamics
• Fig. 86 South Korea next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Latin America next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Brazil key country dynamics
• Fig. 89 Brazil next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Argentina key country dynamics
• Fig. 91 Argentina next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 MEA next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 South Africa key country dynamics
• Fig. 94 South Africa next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 95 Saudi Arabia key country dynamics
• Fig. 96 Saudi Arabia next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 97 UAE key country dynamics
• Fig. 98 UAE next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 99 Kuwait key country dynamics
• Fig. 100 Kuwait next-generation sequencing library preparation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 101 Key company categorization
• Fig. 102 Company market positioning, 2023
• Fig. 103 Strategy framework

Next-generation Sequencing Library Preparation Market Growth & Trends:

The global next-generation sequencing library preparation market size was estimated at USD 3.64 billion in 2030 and is expected to grow at a CAGR of 13.0% from 2024 to 2030, owing the to increasing prevalence of genetic diseases, decreasing costs of sequencing, and rising usage of NGS in disease diagnostics. Moreover, numerous market players offer a broad spectrum of solutions for NGS library preparation to suit the specific requirements of NGS-based analysis.

Advancements in sequencing technology boost the demand for disease panels. NGS libraries are prepared by using nucleotide amplification and sequencing of a specific gene that is causative of a disease condition. The disease diagnosis panels are precisely designed to analyze specific genetic characteristics of a disease condition. For instance, in February 2022, the OncoDNA introduced OncoDEEP kit for analysis of translocations, somatic variants, genomic signatures and predictive biomarkers to aid cancer therapy. The kit also effectively measures tumor mutational burden, microsatellite instability, and loss of heterozygosity.

The COVID-19 pandemic had a significant impact on the adoption of sequencing technology for metagenomics and diagnostics. Furthermore, several key players launched their NGS-based diagnostic tests for COVID-19 and other viral infections. For instance, in April 2021, QIAGEN N.V. released its first-ever QIAseq SARS-CoV-2 diagnostic kit, to be used for the enrichment of the COVID-19 genome and library preparation solution to yield a sequence of the SARS-CoV-2 genome.

Moreover, the growing incidence of diseases and the demand for novel drug discovery, collectively foster the growth of the market. For instance, in September 2022, IDT launches an NGS library preparation solution, xGen monkeypox virus amplicon panel for the precise detection of monkeypox viral infection by genotyping using viral DNA by construction of an NGS library.

Whole-Exome Sequencing is essentially used for the detection of rare genetic disorders by detecting expressive biomarkers that feature mutations, that are causative of various disease conditions. Further, the Whole-Genome Sequencing (WGS) is used for the detection of novel genetic mutations in rare diseases. For instance, in January 2022, researchers at the University of Stanford secured a first-ever Guinness record for a sequencing technique by sequencing a whole human genome in the least turnaround time with a record diagnostic rate for rare disease diagnosis.

Next-generation Sequencing Library Preparation Market Report Highlights:

• By sequencing type, targeted genome sequencing is expected to occupy the larger share in NGS library preparation market due to demand for disease specific analysis of the genome sequence that can cause the disease condition.
• Based on product, the reagents & consumables segment is expected to occupy the bigger share of market space due to the utilitarian benefits that an NGS library preparation kit could offer researchers and clinicians. Ready-to-use NGS library preparation kits require less expertise and bare minimal laboratory infrastructure.
• By application, the drug & biomarker discovery segment dominated the market due to the rise in demand for the discovery of novel drugs and biomarkers for a broad spectrum of disease conditions.
• By end use, Hospital & Clinics segment is expected to grow rapidly over the forecast period owing to the rise in the incidence of cancer, genetic disorders, and other diseases across the globe. The rise in genetic level understanding also positively impacts the growth of this segment.
• North America dominated the global NGS library preparation market in 2022, owing to the rising prevalence of diseases, increasing demand for early diagnosis, the need for genome sequencing, and the presence of key market players.
• Key players in the NGS library preparation market include Agilent Technologies, Inc., Integrated DNA Technologies, F. Hoffmann-La Roche AG, Inc., Illumina, Inc., Beckman Coulter Inc. (Danaher Corporation), Becton, Merck KGaA, Dickinson and Company, New England Biolabs, Inc., PerkinElmer Inc., QIAGEN N.V., Pacific Biosciences of California

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Sequencing Type Segment
  • 1.2.2. Product Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Next-generation Sequencing Library Preparation Market - Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements in Next-generation Sequencing Techniques
    • 3.2.1.2. Rising Interest in Genomics Research and Personalized Medicine
    • 3.2.1.3. Increasing Applications of NGS in Clinical Diagnostics
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data Storage and Management Challenges
    • 3.2.2.2. Ethical and Privacy Concerns Related To The Use of Sequencing Technologies
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Next-generation Sequencing Library Preparation Market: Sequencing Type Business Analysis

• 4.1. Sequencing Type Segment Dashboard
• 4.2. Global Next-generation Sequencing Library Preparation Market Sequencing Type Movement Analysis, 2023 & 2030
• 4.3. Global Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Sequencing Type, 2018 to 2030 (USD Million)
• 4.4. Targeted Genome Sequencing
  • 4.4.1. Global Targeted Genome Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.5. Whole Genome Sequencing
  • 4.5.1. Global Whole Genome Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.6. Whole Exome Sequencing
  • 4.6.1. Global Whole Exome Sequencing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.7. Other Sequencing Types
  • 4.7.1. Global Other Sequencing Types Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Next-generation Sequencing Library Preparation Market: Product Business Analysis

• 5.1. Product Segment Dashboard
• 5.2. Global Next-generation Sequencing Library Preparation Market Product Movement Analysis, 2023 & 2030
• 5.3. Global Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Reagents & Consumables
  • 5.4.1. Global Reagents & Consumables Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. DNA Library Preparation Kits
    • 5.4.2.1. Global DNA Library Preparation Kits Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Library Preparation Kits
    • 5.4.3.1. Global Library Preparation Kits Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. RNA Library Preparation Kits
    • 5.4.4.1. Global RNA Library Preparation Kits Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5. Other Reagents & Consumables
    • 5.4.5.1. Global Other Reagents & Consumables Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5. Instruments
  • 5.5.1. Global Instruments Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Next-generation Sequencing Library Preparation Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Next-generation Sequencing Library Preparation Market Application Movement Analysis, 2023 & 2030
• 6.3. Global Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Drug & Biomarker Discovery
  • 6.4.1. Global Drug & Biomarker Discovery Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Disease Diagnostics
  • 6.5.1. Global Disease Diagnostics Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Cancer Diagnostics
    • 6.5.2.1. Global Cancer Diagnostics Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Reproductive Health Diagnostics
    • 6.5.3.1. Global Reproductive Health Diagnostics Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Infectious Disease Diagnostics
    • 6.5.4.1. Global Infectious Disease Diagnostics Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Other Disease Diagnostic Applications
    • 6.5.5.1. Global Other Disease Diagnostic Applications Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Global Others Next-generation Sequencing Library Preparation Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Next-generation Sequencing Library Preparation Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Next-generation Sequencing Library Preparation Market End Use Movement Analysis, 2023 & 2030
• 7.3. Global Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Global Hospitals and Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Academic and Research Institutions
  • 7.5.1. Global Academic and Research Institutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Pharmaceutical and Biotechnology Companies
  • 7.6.1. Global Pharmaceutical and Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Next-generation Sequencing Library Preparation Market: Regional Estimates & Trend Analysis by Sequencing Type, Product, Application, and End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Target Disease Prevalence
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Regulatory framework
    • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Target disease prevalence
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Regulatory framework
    • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Target disease prevalence
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Regulatory framework
    • 8.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Target disease prevalence
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Regulatory framework
    • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Target disease prevalence
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Regulatory framework
    • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Target disease prevalence
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Regulatory framework
    • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Target disease prevalence
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Regulatory framework
    • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Target disease prevalence
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Regulatory framework
    • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Target disease prevalence
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Regulatory framework
    • 8.5.7.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Target disease prevalence
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Regulatory framework
    • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Target disease prevalence
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Regulatory framework
    • 8.5.9.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Target disease prevalence
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Regulatory framework
    • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Target disease prevalence
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Regulatory framework
    • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Target disease prevalence
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Regulatory framework
    • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Target disease prevalence
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Regulatory framework
    • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Target disease prevalence
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Regulatory framework
    • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Target disease prevalence
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Regulatory framework
    • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Target disease prevalence
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Regulatory framework
    • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Target disease prevalence
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Regulatory framework
    • 8.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Target disease prevalence
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Regulatory framework
    • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Target disease prevalence
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Regulatory framework
    • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Target disease prevalence
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Regulatory framework
    • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Target disease prevalence
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Regulatory framework
    • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. Illumina, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Agilent Technologies, Inc.
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. F. Hoffmann-La Roche AG, Inc.
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Danaher Corporation
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. BD
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Merck KGaA
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Oxford Nanopore Technologies
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. New England Biolabs Inc.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Revvity, Inc.
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. QIAGEN N.V.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Pacific Biosciences of California, Inc.
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. Thermo Fisher Scientific Inc.
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Tecan Group Ltd
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives